» Articles » PMID: 22890722

Interleukin-10 and Interleukin-10-receptor Defects in Inflammatory Bowel Disease

Overview
Date 2012 Aug 15
PMID 22890722
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory disease characterized by abdominal pain, bloody diarrhoea, and malabsorption leading to weight loss. It is considered the result of inadequate control of an excessive reaction of the immune system to the resident flora of the gut. Like other primary immunodeficiencies, IL-10 and IL-10 receptor (IL10R) deficiency present with IBD and demonstrate the sensitivity of the intestine to any changes of the immune system. Both IL-10 and IL10R deficiency cause severe early-onset enterocolitis and can be successfully treated by hematopoietic stem cell transplantation (HSCT).

Citing Articles

Therapeutic Effects of on Intestinal Inflammation and Network Pharmacological Mechanism Analysis in a Dextran Sodium Sulfate-Induced Colitis Mouse Model.

Choi W, Ko S, Jung D, Kim S, Choi N, Park J Nutrients. 2024; 16(20).

PMID: 39458516 PMC: 11510417. DOI: 10.3390/nu16203521.


Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?.

Hardtke-Wolenski M, Landwehr-Kenzel S Mol Cell Pediatr. 2024; 11(1):3.

PMID: 38507159 PMC: 10954601. DOI: 10.1186/s40348-024-00176-8.


Sterile Fecal Microbiota Transplantation Boosts Anti-Inflammatory T-Cell Response in Ulcerative Colitis Patients.

Chechushkov A, Desyukevich P, Yakovlev T, Al Allaf L, Shrainer E, Morozov V Int J Mol Sci. 2024; 25(3).

PMID: 38339169 PMC: 10856413. DOI: 10.3390/ijms25031886.


A novel biallelic 19-bp deletion in the IL10RB gene caused infant-onset inflammatory bowel disease in a consanguineous family: a molecular docking simulation study and literature review.

Motallebi F, Al Sudani Z, Vaghefi F, Khosravi T, Rahimzadeh A, Kowsari A Mol Biol Rep. 2024; 51(1):223.

PMID: 38281300 DOI: 10.1007/s11033-024-09248-4.


The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions.

Carlini V, Noonan D, Abdalalem E, Goletti D, Sansone C, Calabrone L Front Immunol. 2023; 14:1161067.

PMID: 37359549 PMC: 10287165. DOI: 10.3389/fimmu.2023.1161067.


References
1.
Lindsay J, Ciesielski C, Scheinin T, Brennan F, Hodgson H . Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut. 2003; 52(7):981-7. PMC: 1773714. DOI: 10.1136/gut.52.7.981. View

2.
Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F . Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 2010; 117(5):1522-9. DOI: 10.1182/blood-2010-07-298372. View

3.
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan A . IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-44. PMC: 2157567. DOI: 10.1172/JCI33194. View

4.
van Deventer S, Elson C, Fedorak R . Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology. 1997; 113(2):383-9. DOI: 10.1053/gast.1997.v113.pm9247454. View

5.
Xavier R, Podolsky D . Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448(7152):427-34. DOI: 10.1038/nature06005. View